News A single mutation could make H5N1 flu a human threat A single mutation in the H5N1 strain of avian influenza that is infecting cows in the US could make it more likely to infect humans, warn researchers.
News Scripps study claims rebate system does inflate drug prices The pharma industry has been claiming for years that the rebate system is a key factor in driving price increases in the US.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.